Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

January 1992

Volume 644 QT Prolongation and Ventricular Arrhythmias

Pages ix–ix, 1–245

  1. Preface

    1. Top of page
    2. Preface
    3. Part I. Ionic Mechanisms
    4. Part II. Early Afterdepolarization and Triggered Activity
    5. Part III. Acquired Long QT Syndrome
    6. Part IV. Experimental QT Prolongation
    7. Part V. Hereditary Long QT Syndrome
    8. Part VI. ToIsades de Pointes
    9. Part VII. Class III Antiarrhythmic Drugs: Basic
    10. Part VIII. Class III Antiarrhythmic Drugs: Clinical
    1. Preface (page ix)

      Kunitake Hashiba, Arthur j. Moss and Peter j. SCHWARTZ

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb30997.x

  2. Part I. Ionic Mechanisms

    1. Top of page
    2. Preface
    3. Part I. Ionic Mechanisms
    4. Part II. Early Afterdepolarization and Triggered Activity
    5. Part III. Acquired Long QT Syndrome
    6. Part IV. Experimental QT Prolongation
    7. Part V. Hereditary Long QT Syndrome
    8. Part VI. ToIsades de Pointes
    9. Part VII. Class III Antiarrhythmic Drugs: Basic
    10. Part VIII. Class III Antiarrhythmic Drugs: Clinical
  3. Part II. Early Afterdepolarization and Triggered Activity

    1. Top of page
    2. Preface
    3. Part I. Ionic Mechanisms
    4. Part II. Early Afterdepolarization and Triggered Activity
    5. Part III. Acquired Long QT Syndrome
    6. Part IV. Experimental QT Prolongation
    7. Part V. Hereditary Long QT Syndrome
    8. Part VI. ToIsades de Pointes
    9. Part VII. Class III Antiarrhythmic Drugs: Basic
    10. Part VIII. Class III Antiarrhythmic Drugs: Clinical
    1. Cellular Mechanisms of Early Afterdepolarizations (pages 23–32)

      CRAIG T. JANUARY and ADRIANA MOSCUCCI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb30999.x

    2. Multiple Ionic Mechanisms of Early Afterdepolarizations in Isolated Ventricular Myocytes from Guinea-pig Hearts (pages 33–47)

      MASAYASU HIRAOKA, AKIHIKO SUNAMI, ZHENG FAN and TOHRU SAWANOBORI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb31000.x

  4. Part III. Acquired Long QT Syndrome

    1. Top of page
    2. Preface
    3. Part I. Ionic Mechanisms
    4. Part II. Early Afterdepolarization and Triggered Activity
    5. Part III. Acquired Long QT Syndrome
    6. Part IV. Experimental QT Prolongation
    7. Part V. Hereditary Long QT Syndrome
    8. Part VI. ToIsades de Pointes
    9. Part VII. Class III Antiarrhythmic Drugs: Basic
    10. Part VIII. Class III Antiarrhythmic Drugs: Clinical
    1. Acquired Long QT Syndrome due to Antiarrhythmic Drugs and Bradyarrhythmias (pages 57–73)

      HIROSHI KASANUKI, SATOSHI OHNISHI, KOJI TAMURA, TAKASHI NIREI, MORIO SHODA and SAICHI HOSODA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb31002.x

  5. Part IV. Experimental QT Prolongation

    1. Top of page
    2. Preface
    3. Part I. Ionic Mechanisms
    4. Part II. Early Afterdepolarization and Triggered Activity
    5. Part III. Acquired Long QT Syndrome
    6. Part IV. Experimental QT Prolongation
    7. Part V. Hereditary Long QT Syndrome
    8. Part VI. ToIsades de Pointes
    9. Part VII. Class III Antiarrhythmic Drugs: Basic
    10. Part VIII. Class III Antiarrhythmic Drugs: Clinical
    1. Experimental QT Interval Prolongation (pages 74–83)

      GABRIELLA MALFATTO, SUSAN F. STEINBERG, TOVE S. ROSEN, PETER DANILO JR. and MICHAEL R. ROSEN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb31003.x

    2. A Cellular Basis for the Prolonged QT Interval in Mammals (pages 84–92)

      MORDECHAI MANOACH, AMOS FEIN, ZIPORA HECHT and DALIA VARON

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb31004.x

  6. Part V. Hereditary Long QT Syndrome

    1. Top of page
    2. Preface
    3. Part I. Ionic Mechanisms
    4. Part II. Early Afterdepolarization and Triggered Activity
    5. Part III. Acquired Long QT Syndrome
    6. Part IV. Experimental QT Prolongation
    7. Part V. Hereditary Long QT Syndrome
    8. Part VI. ToIsades de Pointes
    9. Part VII. Class III Antiarrhythmic Drugs: Basic
    10. Part VIII. Class III Antiarrhythmic Drugs: Clinical
    1. Clinical Aspects of the Idiopathic Long QT Syndrome (pages 103–111)

      ARTHUR J. MOSS and JENNIFER L. ROBINSON

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb31006.x

    2. Pathogenesis and Therapy of the Idiopathic Long QT Syndrome (pages 112–141)

      PETER J. SCHWARTZ, OSCAR BONAZZI, EMANUELA LOCATI, CARLO NAPOLITANO and SERGIO SALA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb31007.x

  7. Part VI. ToIsades de Pointes

    1. Top of page
    2. Preface
    3. Part I. Ionic Mechanisms
    4. Part II. Early Afterdepolarization and Triggered Activity
    5. Part III. Acquired Long QT Syndrome
    6. Part IV. Experimental QT Prolongation
    7. Part V. Hereditary Long QT Syndrome
    8. Part VI. ToIsades de Pointes
    9. Part VII. Class III Antiarrhythmic Drugs: Basic
    10. Part VIII. Class III Antiarrhythmic Drugs: Clinical
    1. A New Look at Torsades de Pointes (pages 157–177)

      G. FONTAINE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb31009.x

    2. Induction of TU Abnormalities in Patients with Torsades de Pointes (pages 178–186)

      TOHRU OHE, TAKASHI KURITA, WATARU SHIMIZU, TETSURO EMORI and KATSURO SHIMOMURA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb31010.x

  8. Part VII. Class III Antiarrhythmic Drugs: Basic

    1. Top of page
    2. Preface
    3. Part I. Ionic Mechanisms
    4. Part II. Early Afterdepolarization and Triggered Activity
    5. Part III. Acquired Long QT Syndrome
    6. Part IV. Experimental QT Prolongation
    7. Part V. Hereditary Long QT Syndrome
    8. Part VI. ToIsades de Pointes
    9. Part VII. Class III Antiarrhythmic Drugs: Basic
    10. Part VIII. Class III Antiarrhythmic Drugs: Clinical
    1. Controlling Cardiac Arrhythmias by Lengthening Repolarization: Rationale from Experimental Findings and Clinical Considerations (pages 187–209)

      BRAMAH N. SINGH, JONNALAGEDDA S. M. SARMA, ZHI-HAO ZHANG and CHIEI TAKANAKA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb31011.x

    2. Effects of Amiodarone and Bepridil on Ventricular Depolarization and Repolarization (pages 210–222)

      ITSUO KODAMA, HARUO HONJO, TOSHIYUKI OSAKA, KAICHIRO KAMIYA, HIROKAZU IWATA and JUNJI TOYAMA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb31012.x

  9. Part VIII. Class III Antiarrhythmic Drugs: Clinical

    1. Top of page
    2. Preface
    3. Part I. Ionic Mechanisms
    4. Part II. Early Afterdepolarization and Triggered Activity
    5. Part III. Acquired Long QT Syndrome
    6. Part IV. Experimental QT Prolongation
    7. Part V. Hereditary Long QT Syndrome
    8. Part VI. ToIsades de Pointes
    9. Part VII. Class III Antiarrhythmic Drugs: Basic
    10. Part VIII. Class III Antiarrhythmic Drugs: Clinical
    1. Class III Drugs: Their Effects on Arrhythmias and on the QT Interval (pages 223–234)

      RONALD CAMPBELL and ANDREAS LOAIZA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1992.tb31013.x

SEARCH

SEARCH BY CITATION